PD

Pierre Drion

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels

Description

Pierre Drion - CEO @ Petercam

Investor Profile

Pierre Drion has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Belgium.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series A (40%)
  • Series B (40%)
  • Series Unknown (20%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Therapeutics
  • 3d Technology
  • Artificial Intelligence (Ai)
  • Medical Device
  • Software
  • Biopharma
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pierre Drion frequently co-invest with?

New Science Ventures
North America, Connecticut, United States, Greenwich
Co-Investments: 2
NV
Europe, Brabant Wallon, Belgium, Mont-saint-guibert
Co-Investments: 1
TS
North America, Wisconsin, United States, Belgium
Co-Investments: 2
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Qbic Fund
North America, Wisconsin, United States, Belgium
Co-Investments: 1
CL
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
Theodorus III
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
N
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 1
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 2

Which angels does Pierre Drion often collaborate with?

OV
Europe, Belgium
Shared Deals: 1

What are some of recent deals done by Pierre Drion?

Santero Therapeutics

Charleroi, Hainaut, Belgium

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.

BiotechnologyHealth CareTherapeutics
Series AJun 8, 2023
Amount Raised: $8,625,644
Novadip Biosciences

Mont-saint-guibert, Brabant Wallon, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 3, 2022
Amount Raised: $23,398,518
A-Mansia Biotech

Louvain-la-neuve, Vlaams-Brabant, Belgium

A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium.

BiopharmaBiotechnologyLife Science
Series AApr 27, 2018
Amount Raised: $15,790,497
Ovizio

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Ovizio develops digital holographic interferometric microscopy products.

3D TechnologyArtificial Intelligence (AI)BiotechnologyLife ScienceMedical DeviceSoftware
Series UnknownNov 16, 2015
Amount Raised: $8,548,068
Ogeda

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Ogeda is a privately owned clinical-stage drug discovery company.

BiotechnologyHealth CareHealth DiagnosticsPharmaceutical
Series BOct 2, 2015
Amount Raised: $17,937,924